573 related articles for article (PubMed ID: 20923787)
1. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.
Sauer SW; Opp S; Hoffmann GF; Koeller DM; Okun JG; Kölker S
Brain; 2011 Jan; 134(Pt 1):157-70. PubMed ID: 20923787
[TBL] [Abstract][Full Text] [Related]
2. Inherited Disorders of Lysine Metabolism: A Review.
Bouchereau J; Schiff M
J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
[TBL] [Abstract][Full Text] [Related]
3. Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.
Biagosch C; Ediga RD; Hensler SV; Faerberboeck M; Kuehn R; Wurst W; Meitinger T; Kölker S; Sauer S; Prokisch H
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2220-2228. PubMed ID: 28545977
[TBL] [Abstract][Full Text] [Related]
4. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
Kölker S; Boy SP; Heringer J; Müller E; Maier EM; Ensenauer R; Mühlhausen C; Schlune A; Greenberg CR; Koeller DM; Hoffmann GF; Haege G; Burgard P
Mol Genet Metab; 2012 Sep; 107(1-2):72-80. PubMed ID: 22520952
[TBL] [Abstract][Full Text] [Related]
5. Deletion of 2-aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1.
Leandro J; Dodatko T; DeVita RJ; Chen H; Stauffer B; Yu C; Houten SM
J Inherit Metab Dis; 2020 Nov; 43(6):1154-1164. PubMed ID: 32567100
[TBL] [Abstract][Full Text] [Related]
6. Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.
Sauer SW; Opp S; Komatsuzaki S; Blank AE; Mittelbronn M; Burgard P; Koeller DM; Okun JG; Kölker S
Biochim Biophys Acta; 2015 May; 1852(5):768-77. PubMed ID: 25558815
[TBL] [Abstract][Full Text] [Related]
7. Understanding cerebral L-lysine metabolism: the role of L-pipecolate metabolism in Gcdh-deficient mice as a model for glutaric aciduria type I.
Posset R; Opp S; Struys EA; Völkl A; Mohr H; Hoffmann GF; Kölker S; Sauer SW; Okun JG
J Inherit Metab Dis; 2015 Mar; 38(2):265-72. PubMed ID: 25214427
[TBL] [Abstract][Full Text] [Related]
8. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
[TBL] [Abstract][Full Text] [Related]
9. The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery.
Gonzalez Melo M; Remacle N; Cudré-Cung HP; Roux C; Poms M; Cudalbu C; Barroso M; Gersting SW; Feichtinger RG; Mayr JA; Costanzo M; Caterino M; Ruoppolo M; Rüfenacht V; Häberle J; Braissant O; Ballhausen D
Mol Genet Metab; 2021 Jun; 133(2):157-181. PubMed ID: 33965309
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx.
Strauss KA; Brumbaugh J; Duffy A; Wardley B; Robinson D; Hendrickson C; Tortorelli S; Moser AB; Puffenberger EG; Rider NL; Morton DH
Mol Genet Metab; 2011; 104(1-2):93-106. PubMed ID: 21820344
[TBL] [Abstract][Full Text] [Related]
11. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.
Boy N; Mühlhausen C; Maier EM; Heringer J; Assmann B; Burgard P; Dixon M; Fleissner S; Greenberg CR; Harting I; Hoffmann GF; Karall D; Koeller DM; Krawinkel MB; Okun JG; Opladen T; Posset R; Sahm K; Zschocke J; Kölker S;
J Inherit Metab Dis; 2017 Jan; 40(1):75-101. PubMed ID: 27853989
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
Guerreiro G; Faverzani J; Moura AP; Volfart V; Gome Dos Reis B; Sitta A; Gonzalez EA; de Lima Rosa G; Coitinho AS; Baldo G; Wajner M; Vargas CR
Arch Biochem Biophys; 2021 Sep; 709():108970. PubMed ID: 34181873
[TBL] [Abstract][Full Text] [Related]
13. Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.
Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
[TBL] [Abstract][Full Text] [Related]
14. Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Amaral AU; Cecatto C; Seminotti B; Ribeiro CA; Lagranha VL; Pereira CC; de Oliveira FH; de Souza DG; Goodman S; Woontner M; Wajner M
Brain Res; 2015 Sep; 1620():116-29. PubMed ID: 25998543
[TBL] [Abstract][Full Text] [Related]
15. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
[TBL] [Abstract][Full Text] [Related]
16. Impairment of astrocytic glutaminolysis in glutaric aciduria type I.
Komatsuzaki S; Ediga RD; Okun JG; Kölker S; Sauer SW
J Inherit Metab Dis; 2018 Jan; 41(1):91-99. PubMed ID: 29098534
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of glutaric aciduria type I--revised recommendations.
Kölker S; Christensen E; Leonard JV; Greenberg CR; Boneh A; Burlina AB; Burlina AP; Dixon M; Duran M; García Cazorla A; Goodman SI; Koeller DM; Kyllerman M; Mühlhausen C; Müller E; Okun JG; Wilcken B; Hoffmann GF; Burgard P
J Inherit Metab Dis; 2011 Jun; 34(3):677-94. PubMed ID: 21431622
[TBL] [Abstract][Full Text] [Related]
18. Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I.
Herskovitz M; Goldsher D; Sela BA; Mandel H
Neurology; 2013 Aug; 81(9):849-50. PubMed ID: 23884036
[TBL] [Abstract][Full Text] [Related]
19. The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies.
Leandro J; Houten SM
Mol Genet Metab; 2020; 131(1-2):14-22. PubMed ID: 32768327
[TBL] [Abstract][Full Text] [Related]
20. Low lysine diet in glutaric aciduria type I--effect on anthropometric and biochemical follow-up parameters.
Boy N; Haege G; Heringer J; Assmann B; Mühlhausen C; Ensenauer R; Maier EM; Lücke T; Hoffmann GF; Müller E; Burgard P; Kölker S
J Inherit Metab Dis; 2013 May; 36(3):525-33. PubMed ID: 22971958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
